- Asian equities drift lower even as Australia, India and Indonesia mark mild gains.
- Beijing inflation likely to improve, vaccines can’t assure guaranteed strength against covid variants.
- Aussie employment figures confirmed RBA’s downbeat expectations.
Global traders fail to offer a warm welcome to Chinese counterparts as markets in Asia-Pacific remain sluggish, mostly negative, during early Thursday. The risk catalyst wobbles as Beijing couldn’t offer any key reaction to the latest shift in risk while the coronavirus (COVID-19) vaccine news flash mixed signals.
That said, MSCI’s index of Asia-Pacific shares outside Japan drops 0.17% whereas Japan’s Nikkei follows the suit with 0.23% despite BoJ Governor Haruhiko Kuroda’s efforts to recall buyers. Further, stocks in China pare initial gains even as Financial Times suggest inflation run-up in the dragon nation.
Elsewhere, the Australian equities buck the trend with mild gains, joining the league of India’s BSE Sensex and Indonesia’s IDX Composite, as eight-month low of Aussie Unemployment Rate couldn’t defy weak Employment Change and Participation Rate for January.
It should be noted that South Korea’s KOSPI becomes the biggest loser with over 1.0% downside amid a lack of major catalysts and tussle with its neighbor in the North.
Wall Street also closed mixed the previous day even as FOMC minutes helped to recover some of the early-day losses due to the strong US dollar and upbeat data from America. The same could be observed in S&P 500 Futures so far whereas the US 10-year Treasury yields remain depressed for one more day after rising to the yearly high the previous day.
Read: S&P 500 Futures, US Treasury yields dwindle amid China’s return, mixed vaccine news
Looking forward, global market players await China’s reaction to the US dislike for Beijing’s policies as well as the latest vaccine pessimism, mainly due to doubts over whether the jabs can tame the covid variants or not. Also important will be the ECB minutes and US Jobless Claims.
Share
